Anakinra compared to prednisone in the treatment of acute CPPD crystal arthritis: A randomized controlled double-blinded pilot study

Joint Bone Spine. 2021 Mar;88(2):105088. doi: 10.1016/j.jbspin.2020.105088. Epub 2020 Oct 29.

Authors

Alexandre Dumusc¹, Borbala Pazar Maldonado², Charles Benaim³, Pascal Zufferey², Bérengère Aubry-Rozier², Alexander So²

Affiliations

¹ Rheumatology Department, Lausanne University Hospital, avenue Pierre-Decker 4, 1005 Lausanne, Switzerland. Electronic address: alexandre.dumusc@chuv.ch.
² Rheumatology Department, Lausanne University Hospital, avenue Pierre-Decker 4, 1005 Lausanne, Switzerland.
³ Physical Medicine and Rehabilitation Department, Lausanne University Hospital, 1005 Lausanne, Switzerland.

PMID: 33445133
DOI: 10.1016/j.jbspin.2020.105088

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Arthritis*
Calcium Pyrophosphate
Chondrocalcinosis*
Crystal Arthropathies*
Double-Blind Method
Humans
Interleukin 1 Receptor Antagonist Protein
Pilot Projects
Prednisone / therapeutic use

Substances

Interleukin 1 Receptor Antagonist Protein
Prednisone
Calcium Pyrophosphate